Health Condition 1: L409- Psoriasis, unspecified
Conditions
Interventions
Intervention1: Mujun Mundi (oral) and Qairooti Karnab (Ointment): Majun Mundi is given 5 gm BD for 84 days.
Qairooti Karnab ointment is applied topically on the affected psoriatic lesions.
Interventio
Sponsors
Central Council for research in Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with Psoriasis who are willing to participate in the study.
Exclusion criteria
Exclusion criteria: The Subjects who are unwilling to give the blood sample. Pregnant women, lactating women, cancer patients and mentally disorder people
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢This study will be providing the expression levels of leptin gene association in psoriasis patients with clinical phenotyping along with the proinflammatory cytokines. This study will reveal the gene expression levels after the drug treatment. Thus, this study may provide possible association of expression level in psoriasis related to clinical phenotyping and clinical pattern of the disease.Timepoint: baseline, 4th month | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Determination of dominant Temperament by special CRF based on Unani Philosophy of Medicine.Timepoint: baseline , 4th month | — |
Countries
India
Contacts
Public ContactTasleem Ahmed
NRIUMSD, Hyderabad
Outcome results
None listed